Literature DB >> 21837751

Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.

Ainara Cano1, Xabier Buqué, Maite Martínez-Uña, Igor Aurrekoetxea, Ariane Menor, Juan L García-Rodríguez, Shelly C Lu, M Luz Martínez-Chantar, José M Mato, Begoña Ochoa, Patricia Aspichueta.   

Abstract

UNLABELLED: Very low-density lipoprotein (VLDL) secretion provides a mechanism to export triglycerides (TG) from the liver to peripheral tissues, maintaining lipid homeostasis. In nonalcoholic fatty liver disease (NAFLD), VLDL secretion disturbances are unclear. Methionine adenosyltransferase (MAT) is responsible for S-adenosylmethionine (SAMe) synthesis and MAT I and III are the products of the MAT1A gene. Deficient MAT I and III activities and SAMe content in the liver have been associated with NAFLD, but whether MAT1A is required for normal VLDL assembly remains unknown. We investigated the role of MAT1A on VLDL assembly in two metabolic contexts: in 3-month-old MAT1A-knockout mice (3-KO), with no signs of liver injury, and in 8-month-old MAT1A-knockout mice (8-KO), harboring nonalcoholic steatohepatitis. In 3-KO mouse liver, there is a potent effect of MAT1A deletion on lipid handling, decreasing mobilization of TG stores, TG secretion in VLDL and phosphatidylcholine synthesis via phosphatidylethanolamine N-methyltransferase. MAT1A deletion also increased VLDL-apolipoprotein B secretion, leading to small, lipid-poor VLDL particles. Administration of SAMe to 3-KO mice for 7 days recovered crucial altered processes in VLDL assembly and features of the secreted lipoproteins. The unfolded protein response was activated in 8-KO mouse liver, in which TG accumulated and the phosphatidylcholine-to-phosphatidylethanolamine ratio was reduced in the endoplasmic reticulum, whereas secretion of TG and apolipoprotein B in VLDL was increased and the VLDL physical characteristics resembled that in 3-KO mice. MAT1A deletion also altered plasma lipid homeostasis, with an increase in lipid transport in low-density lipoprotein subclasses and decrease in high-density lipoprotein subclasses.
CONCLUSION: MAT1A is required for normal VLDL assembly and plasma lipid homeostasis in mice. Impaired VLDL synthesis, mainly due to SAMe deficiency, contributes to NAFLD development in MAT1A-KO mice.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21837751      PMCID: PMC3222787          DOI: 10.1002/hep.24607

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

1.  Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein.

Authors:  F Benoist; T Grand-Perret
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.

Authors:  Z M Yao; D E Vance
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

3.  Purification and properties of a cholesteryl ester hydrolase from rat liver microsomes.

Authors:  S Cristóbal; B Ochoa; O Fresnedo
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

4.  S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes.

Authors:  Maria Lauda Tomasi; Komal Ramani; Fernando Lopitz-Otsoa; Manuel S Rodríguez; Tony W H Li; Kwangsuk Ko; Heping Yang; Fawzia Bardag-Gorce; Ainhoa Iglesias-Ara; Francesco Feo; Maria Rosa Pascale; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

5.  Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone.

Authors:  Vernon W Dolinsky; Donna N Douglas; Richard Lehner; Dennis E Vance
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

6.  Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion.

Authors:  R A Borchardt; R A Davis
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

7.  Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.

Authors:  Tsuguhito Ota; Constance Gayet; Henry N Ginsberg
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

8.  Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.

Authors:  Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy
Journal:  J Lipid Res       Date:  2008-06-01       Impact factor: 5.922

Review 9.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

10.  Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver.

Authors:  Franck Rencurel; Marc Foretz; Michel R Kaufmann; Deborah Stroka; Renate Looser; Isabelle Leclerc; Gabriela da Silva Xavier; Guy A Rutter; Benoit Viollet; Urs A Meyer
Journal:  Mol Pharmacol       Date:  2006-09-20       Impact factor: 4.436

View more
  32 in total

Review 1.  Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors:  Mazen Noureddin; José M Mato; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-13

2.  Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.

Authors:  Susan K Murphy; Hyuna Yang; Cynthia A Moylan; Herbert Pang; Andrew Dellinger; Manal F Abdelmalek; Melanie E Garrett; Allison Ashley-Koch; Ayako Suzuki; Hans L Tillmann; Michael A Hauser; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2013-07-31       Impact factor: 22.682

3.  Methyl-Sensing Nuclear Receptor Liver Receptor Homolog-1 Regulates Mitochondrial Function in Mouse Hepatocytes.

Authors:  Sungwoo Choi; Bingning Dong; Chih-Chun Janet Lin; Mi Jeong Heo; Kang Ho Kim; Zhen Sun; Martin Wagner; Nagireddy Putluri; Jae Myoung Suh; Meng C Wang; David D Moore
Journal:  Hepatology       Date:  2019-12-23       Impact factor: 17.425

Review 4.  Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.

Authors:  Xian-Cheng Jiang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.

Authors:  Cristina Alonso; David Fernández-Ramos; Marta Varela-Rey; Ibon Martínez-Arranz; Nicolás Navasa; Sebastiaan M Van Liempd; José L Lavín Trueba; Rebeca Mayo; Concetta P Ilisso; Virginia G de Juan; Marta Iruarrizaga-Lejarreta; Laura delaCruz-Villar; Itziar Mincholé; Aaron Robinson; Javier Crespo; Antonio Martín-Duce; Manuel Romero-Gómez; Holger Sann; Julian Platon; Jennifer Van Eyk; Patricia Aspichueta; Mazen Noureddin; Juan M Falcón-Pérez; Juan Anguita; Ana M Aransay; María Luz Martínez-Chantar; Shelly C Lu; José M Mato
Journal:  Gastroenterology       Date:  2017-01-26       Impact factor: 22.682

Review 6.  Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.

Authors:  Karen D Corbin; Steven H Zeisel
Journal:  Curr Opin Gastroenterol       Date:  2012-03       Impact factor: 3.287

7.  S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.

Authors:  Maite Martínez-Uña; Marta Varela-Rey; Daniela Mestre; Larraitz Fernández-Ares; Olatz Fresnedo; David Fernandez-Ramos; Virginia Gutiérrez-de Juan; Idoia Martin-Guerrero; Africa García-Orad; Zigmund Luka; Conrad Wagner; Shelly C Lu; Carmelo García-Monzón; Richard H Finnell; Igor Aurrekoetxea; Xabier Buqué; M Luz Martínez-Chantar; José M Mato; Patricia Aspichueta
Journal:  J Hepatol       Date:  2014-10-18       Impact factor: 25.083

Review 8.  Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

Authors:  Peter J Meikle; Scott A Summers
Journal:  Nat Rev Endocrinol       Date:  2016-10-21       Impact factor: 43.330

Review 9.  S-adenosylmethionine in liver health, injury, and cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

Review 10.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.